- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
NeoPharm Co Ltd (092730)
NeoPharm Co Ltd stock price live, this page displays KQ 092730 stock exchange data. View the 092730 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the NeoPharm Co Ltd real time stock price chart below.
What Is the NeoPharm Co Ltd Stock Price Today?
The NeoPharm Co Ltd stock price today is 22,550.
What Is the Stock Symbol for NeoPharm Co Ltd?
The stock ticker symbol for NeoPharm Co Ltd is 092730.
Is 092730 the Same as $092730?
$092730 is a common way to refer to the NeoPharm Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does NeoPharm Co Ltd Trade On?
NeoPharm Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is NeoPharm Co Ltd a Good Stock to Buy?
Determining whether NeoPharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current NeoPharm Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 092730 quote. (ISIN: KR7092730001)
What Is the NeoPharm Co Ltd Stock Price Today?
The NeoPharm Co Ltd stock price today is 22,550.
What Is the Stock Symbol for NeoPharm Co Ltd?
The stock ticker symbol for NeoPharm Co Ltd is 092730.
Is 092730 the Same as $092730?
$092730 is a common way to refer to the NeoPharm Co Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does NeoPharm Co Ltd Trade On?
NeoPharm Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is NeoPharm Co Ltd a Good Stock to Buy?
Determining whether NeoPharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current NeoPharm Co Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 092730 quote. (ISIN: KR7092730001)
KOSDAQ
Currency in KRW
22,550
-500(-2.17%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22,250
23,000
52 wk Range
15,590
26,000
092730 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
22,25023,000
52 wk Range
15,59026,000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
092730 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
24,000
Upside
+6.43%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 24,000
(+6.43% Upside)
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-- / --
Revenue / Forecast
43.6B / 37B
Compare 092730 to Peers and Sector
Metrics to compare | 092730 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship092730PeersSector | |
|---|---|---|---|---|
P/E Ratio | 12.6x | 11.4x | 11.6x | |
PEG Ratio | 0.61 | 0.05 | 0.03 | |
Price / Book | 1.8x | 0.9x | 1.5x | |
Price / LTM Sales | 2.7x | 0.9x | 0.9x | |
Upside (Analyst Target) | 6.4% | 9.6% | 23.1% | |
Fair Value Upside | Unlock | 18.4% | 12.8% | Unlock |
NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the NeoPharm (092730) Stock Price Today?
The NeoPharm stock price today is 22,550 KRW.
What Stock Exchange Does NeoPharm Trade On?
NeoPharm is listed and trades on the KOSDAQ.
What Is the Stock Symbol for NeoPharm?
The stock symbol for NeoPharm is "092730."
Does NeoPharm Pay Dividends? What’s The Current Dividend Yield?
The NeoPharm dividend yield is 3.33%.
What Is the NeoPharm Market Cap?
As of today, NeoPharm market cap is 352.71B KRW.
What Is NeoPharm's Earnings Per Share (TTM)?
The NeoPharm EPS (TTM) is 1,779.
When Is the Next NeoPharm Earnings Date?
NeoPharm will release its next earnings report on Nov 06, 2026.
From a Technical Analysis Perspective, Is 092730 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has NeoPharm Stock Split?
NeoPharm has split 2 times.
How Many Employees Does NeoPharm Have?
NeoPharm has 178 employees.
What is the current trading status of NeoPharm (092730)?
As of Aug 21, 2026, NeoPharm (092730) is trading at a price of 22,550 KRW, with a previous close of 23,050 KRW. The stock has fluctuated within a day range of 22,250 KRW to 23,000 KRW, while its 52-week range spans from 15,590 KRW to 26,000 KRW.
What Is NeoPharm (092730) Price Target According to Analysts?
The average 12-month price target for NeoPharm is 24,000 KRW, with a high estimate of 24000 KRW and a low estimate of 24000 KRW. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +6.43% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.